SeraCare Life Sciences, Inc. (NASDAQ: SRLS) and RayBiotech, Inc. announced today that SeraCare will act as an agent for the sale of RayBiotech’s full product line of antibody arrays, protein arrays, tissue microarrays and ELISA and EIA kits. The synergy of RayBiotech’s innovative portfolio with SeraCare’s global reach and expertise in virology, serology, immunology and molecular biology supports the acceleration of biomedical research and product development.

“The partnership with RayBiotech directly supports SeraCare’s growth strategy by expanding our offering of value-added proteomic tools to life sciences researchers around the world,” said Susan Vogt, President and Chief Executive Officer of SeraCare Life Sciences. “RayBiotech is well regarded in the field of proteomics and their innovative products will benefit our client base while our mutual commitment to science and medicine offers opportunity for clinical advancements.”

“SeraCare is a respected, experienced provider of biological reagents and services to the life science community with a global reach and a motivated sales force,” said Dr. Ray Huang, President of RayBiotech. “By adding SeraCare Life Sciences as an agent, we hope to achieve both increased demand for RayBiotech products in clinical and diagnostic markets and fuel increased opportunity for biomarker discovery and validation.”

RayBiotech first introduced antibody arrays to the market in 2001. Since then, RayBiotech’s antibody arrays have been cited in hundreds of top-tier journals such as Cell, Nature, Nature Medicine, PNAS and Lancet. Their extensive selection of arrays includes the largest panel of human, mouse, or rat protein targets available on a single array. RayBiotech offers choices of semi-quantitative screening arrays and quantitative multiplex ELISA arrays, membrane (chemiluminescence detection) and glass slide (fluorescence detection) array platforms and customized array production services. By offering more options for multiplex protein detection than any other company, RayBiotech remains the leader in protein array technologies. The molecular targets detected by RayBiotech’s arrays include cytokines, chemokines, growth/angiogenic factors, adipokines, soluble receptors, matrix metalloproteases (MMPs) and their inhibitors.

SeraCare Life Sciences offers the highest quality biologically-based products, cellular immunology products and a broad range of related services to facilitate the discovery, development and production of human diagnostics and therapeutics. SeraCare has a worldwide sales force and an extensive history of service to clinical and research laboratories, biopharmaceutical companies and public health agencies including the National Institutes of Health, the Centers for Disease Control and the U.S. Food and Drug Administration.